Discoid lupus can cause persistent scaly scalp patches and permanent scarring hair loss. If a patch is changing in colour, becoming scarred or losing visible follicle openings, diagnosis and control of inflammation come before PRP. It is not safe to assume that every thin area is ordinary pattern hair loss.
For someone planning a hair-restoration course, the most valuable first appointment may be the one that changes the plan. Identifying an inflammatory condition allows treatment to focus on protecting remaining follicles rather than making promises about regrowing a scar.
What is discoid lupus on the scalp?
DermNet describes discoid lupus erythematosus as a chronic scarring skin condition and the most common form of cutaneous lupus. Persistent scaly plaques can affect the scalp, face and ears. Over time they can lead to scarring, skin thinning, colour change and permanent loss of hair in affected areas.
The appearance varies with skin colour and the stage of disease. A patch may show darker or lighter pigment, adherent scale or changes around follicle openings. An internet photograph is not a reliable way to decide what your own patch represents.
Discoid lupus is a skin diagnosis, not automatically a diagnosis of systemic lupus. The clinician considers the extent of skin disease and any wider symptoms when deciding whether investigations or another specialist opinion are needed. Do not infer the answer from the word lupus alone.
Discuss a changing scalp patch before booking PRP.
How is it diagnosed?
The history and examination guide the assessment. DermNet says a skin biopsy usually confirms the diagnosis. The clinician may also arrange tests to assess for wider involvement according to the findings. This does not mean everyone with an itchy scalp needs an extensive lupus panel.
Bring the timeline of the patch, photographs, medicines and details of other symptoms or previous diagnoses. Tell the clinician whether there are similar areas on the face or ears and whether previous creams helped. If a biopsy or specialist letter already exists, take the actual report.
Several scalp conditions can resemble one another. Our lichen planopilaris guide describes a different inflammatory scarring disorder. The fact that both can cause permanent loss does not make their diagnosis or management interchangeable.
Why does scarring change a hair-growth plan?
A hair follicle that has been destroyed and replaced by scar is different from a surviving follicle that has become smaller in pattern hair loss. A treatment aimed at supporting growth cannot be assumed to recreate a lost follicle. That distinction should be explained before any course is sold.
The assessment needs to separate active inflammation, established scarring and any other type of thinning elsewhere on the scalp. These may require different goals and different clinicians. A reassuring plan identifies what can realistically be improved, what needs protection and what remains uncertain.
Photographs can help document change, but the appearance of a central bald area alone does not show whether the edge is active. Review may include examination of the surrounding skin and discussion of symptoms. Ask how activity will be monitored and when the plan should be reconsidered.
Is PRP a treatment for discoid lupus?
The DermNet treatment pathway used for this guide describes measures to control lupus-related inflammation, including prescription local or systemic treatment when appropriate. It does not establish PRP as standard treatment for scalp discoid lupus. Results from pattern-hair-loss studies should not be presented as proof in this condition.
The London PRP Clinic provides hair PRP within its published service range, but that is not a guarantee of suitability for an inflamed or scarred scalp. An assessment may conclude that specialist dermatology care is the right next step instead of an injection appointment.
If a person has stable discoid lupus and a separate hair concern, decisions still need individual review. This guide does not set a safe waiting period, promise that injections are appropriate after a particular interval or tell anyone to stop prescribed treatment.
Ask about diagnosis and suitability before a course.
What does treatment aim to do?
The main aim is to control inflammation and limit further damage. DermNet describes sun protection, stopping smoking and prescription therapies among management options. The exact choice depends on disease activity, extent and the individual's situation.
Do not copy a medicine regimen from another person or use a strong steroid product without the right advice. Treatments have specific risks and monitoring requirements. A clear plan should tell you how to use any prescribed treatment, when to review it and what to do if the patch changes.
Where hair loss is permanent, camouflage or other cosmetic support may be part of care. That can be discussed honestly without abandoning the goal of disease control. Supporting confidence and protecting remaining hair are both legitimate aims, but neither calls for an unsupported regrowth promise.
What should I ask at the consultation?
Ask whether the diagnosis is confirmed, whether the disease looks active and whether a biopsy would change the decision. Ask who will manage follow-up, what improvement should look like and which symptoms need earlier contact.
If a procedure has been suggested elsewhere, bring its name and the proposed treatment area. Ask what evidence supports it in your diagnosis, rather than accepting evidence from a different kind of hair loss. Request a written explanation of the plan and fee before committing to treatment.
A new or expanding scarred patch merits prompt assessment. A routine hair-treatment enquiry is not a substitute for urgent medical advice if you feel unwell or have rapidly worsening symptoms.
Evidence and sources
DermNet, Discoid lupus erythematosus, updated October 2023, supports the clinical features, biopsy role and treatment context. Sources and current clinic service page checked 4 November 2026. This article is general information, not a diagnosis, a specialist referral confirmation or evidence that PRP treats lupus.